Results of a preliminary clinical study suggest that the intrinsic protein-binding properties of biotin can be utilized to enhance radiotherapy after surgery for early-stage breast cancer patients. This new therapy technique, which combines intraoperative avidination for radionuclide therapy (IART) with radioactively tagged biotin (
Since clinical trials show that EBRT post-surgery results in lower recurrence rates, it is considered a standard adjuvant treatment option for early breast cancer. However, it can be a time-consuming process - five treatments a week for up to seven weeks - which may explain why up to 30% of these breast cancer patients opt out of EBRT.31
Researchers suggest that the reduced EBRT treatment times associated with this new technique may make EBRT more palatable - especially for patients who live far from a treatment center - since it can be delivered in any hospital setting. Imaging done in clinical trials utilizing the avidin/biotin radiotherapy delivery system also showed that the radioactive material was quickly taken up and focused in the surgical area. This limited the radioactive material in normal tissue, (including the area surrounding where the tumor had been excised) as well as toxicity in the blood, kidneys, or liver.31
Disclaimer: This website is not intended to replace professional consultation, diagnosis, or treatment by a licensed physician. If you require any medical related advice, contact your physician promptly. Information at Biotin.com is exclusively of a general reference nature. Do not disregard medical advice or delay treatment as a result of accessing information at this site.
A molecule of short half-life radioactive yttrium that emits beta particles (energetic electrons) bound to a biotin molecule.31
Also known as teletherapy.31
A protein in egg whites.9